LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 82 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q3 2018. The put-call ratio across all filers is 0.18 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $11,000 | – | 372 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 3,440,419 | $110,713,000 | 17.54% |
| Consonance Capital Management LP | 2,079,311 | $66,912,000 | 6.04% |
| RTW INVESTMENTS, LP | 1,063,170 | $34,213,000 | 5.71% |
| Broadfin Capital, LLC | 1,029,866 | $33,141,000 | 5.42% |
| Perceptive Advisors | 3,388,611 | $109,046,000 | 3.62% |
| SECTORAL ASSET MANAGEMENT INC | 854,301 | $27,491,000 | 3.44% |
| Boxer Capital, LLC | 267,500 | $8,608,000 | 1.57% |
| Ghost Tree Capital, LLC | 200,000 | $6,436,000 | 1.51% |
| EMORY UNIVERSITY | 51,632 | $1,662,000 | 1.43% |
| Stanley-Laman Group, Ltd. | 168,653 | $5,427,000 | 1.17% |